MolNFT v1 · #50490 · protein
Substrate mimic bound to sgtam
2RJR · Tyrosine aminomutase: “Substrate mimic bound to sgtam”. X-ray diffraction, 1 ligand (295), 10 pockets (best druggability 0.62). MolNFT v1 #50490 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2RJR
- Type
- protein
- Length
- 1,052 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tyrosine aminomutase
- EC
- 5.4.3.6
- UniProt
- Q8GMG0
- Ligands
- 295
- Pockets
- 10 · best druggability 0.62
Structure
x-ray diffraction · 1 distinct chain · 58% helix, 7% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Tyrosine aminomutase (EC 5.4.3.6) | protein | 526 | 58% helix, 7% strand | Q8GMG0 |
Ligands and binding sites
- 295 · (2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid · ligand · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 158 | 0.62 | 0.84 | 32 | empty |
| 2 | 107 | 0.52 | 0.82 | 27 | 295 |
| 3 | 162 | 0.51 | 0.78 | 35 | empty |
| 4 | 138 | 0.39 | 0.74 | 27 | empty |
| 5 | 92 | 0.39 | 0.77 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 4903 Ų buried · 83 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 modified, 1 covalent (nonstandard, covalent ligand).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8GMG0
- Elsewhere: RCSB PDB 2RJR · PDBe 2RJR · UniProt Q8GMG0
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.